In 2024, China's share of scientific publications in the world's top 10% of cited cell biology papers is forecasted to be 11.35%, up from 11.00% in 2023. This indicates a year-on-year increase of 3.18%. By 2028, this figure is expected to grow to 12.69%, representing an average annual growth rate (CAGR) of approximately 3.55% from 2024 to 2028. The trend showcases a consistent growth trajectory in China's prominence in high-impact cell biology research.
- Future trends to watch for:
- Increased investment in research and development by China could bolster this growth further.
- Collaboration with international research institutions may enhance the impact and quality of publications.
- Monitoring shifts in global research funding and policy changes that may affect publication outputs.
